Blue Pearl Agri (514440)

Cyclical

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹46.44
Market Cap₹1.2 Cr
P/E Ratio1,000
ROCE2.57%
ROE2%
Dividend Yield0%
Profit Growth-24.32%
Debt/Equity
Sales Growth32.75%
52-Week Range₹18.98 — ₹105.04
SectorChemicals & Petrochemicals
Book Value₹0.43

Strengths

Concerns

AI Analysis

At ₹46.44, this is a company with a market capitalisation of just ₹1 crore—a microcap so small that it would barely move the needle in any serious portfolio. Graham taught me to pay for assets and earnings, and here I get neither. The book value is ₹0.43 per share, yet the price is 108 times book. Earnings support a P/E of 1,000, while return on equity is only 2% and ROCE is 2.57%. That is not a business; it is a scrap of equity being priced for perfection. Top line grew 32.75%, but bottom line fell 24.32%, and the latest quarter shows sales of ₹14 Cr with net profit of ₹0 Cr. Profit growth and sales growth must eventually align; here they are diverging. The Piotroski F-score of 4 out of 9 says the financial health is poor. With no dividend yield and a PEG ratio of 30.53, whatever growth exists is already more than paid for. Debt/equity and promoter holding are not available—unacceptable in a stock this size. In a commodity chemical business, where products are undifferentiated, there is no moat. Prices are dictated by the market, not by the company. The 52-week range of ₹18.98 to ₹114.61 tells me this is a speculative vehicle, not an investment. Unless there is a genuine, verifiable turnaround in margins and cash flow, the rational move is to stay away. I would need a large margin of safety, clear debt numbers, and evidence that the promoter is invested. None of that exists today. This is not a business to own; it is a ticket to trade. My rule: if I cannot calculate a conservative value with confidence, I move on.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer